212 related articles for article (PubMed ID: 16861350)
1. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance.
Qian Y; Conway KL; Lu X; Seitz HM; Matsushima GK; Clarke SH
Blood; 2006 Aug; 108(3):974-82. PubMed ID: 16861350
[TBL] [Abstract][Full Text] [Related]
2. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice.
Yoshida T; Higuchi T; Hagiyama H; Strasser A; Nishioka K; Tsubata T
Int Immunol; 2000 Apr; 12(4):517-26. PubMed ID: 10744653
[TBL] [Abstract][Full Text] [Related]
3. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
Mandik-Nayak L; Seo SJ; Sokol C; Potts KM; Bui A; Erikson J
J Exp Med; 1999 Jun; 189(11):1799-814. PubMed ID: 10359584
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis.
Skarstein K; Nerland AH; Eidsheim M; Mountz JD; Jonsson R
Scand J Immunol; 1997 Oct; 46(4):373-8. PubMed ID: 9350288
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.
Anstee NS; Vandenberg CJ; Campbell KJ; Hughes PD; O'Reilly LA; Cory S
Cell Death Differ; 2017 Mar; 24(3):397-408. PubMed ID: 27813531
[TBL] [Abstract][Full Text] [Related]
6.
Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
[TBL] [Abstract][Full Text] [Related]
7. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
[TBL] [Abstract][Full Text] [Related]
8. Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.
Honjo K; Kubagawa Y; Suzuki Y; Takagi M; Ohno H; Bucy RP; Izui S; Kubagawa H
Int Immunol; 2014 Dec; 26(12):659-72. PubMed ID: 24994818
[TBL] [Abstract][Full Text] [Related]
9. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
Lenda DM; Stanley ER; Kelley VR
J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
[TBL] [Abstract][Full Text] [Related]
10. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
11. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr.
Drappa J; Brot N; Elkon KB
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10340-4. PubMed ID: 7694292
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.
Mountz JD; Zhou T; Bluethmann H; Wu J; Edwards CK
Int Rev Immunol; 1994; 11(4):321-42. PubMed ID: 7528763
[TBL] [Abstract][Full Text] [Related]
13. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
Yan J; Mamula MJ
Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
[TBL] [Abstract][Full Text] [Related]
14. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
Hutcheson J; Scatizzi JC; Siddiqui AM; Haines GK; Wu T; Li QZ; Davis LS; Mohan C; Perlman H
Immunity; 2008 Feb; 28(2):206-17. PubMed ID: 18275831
[TBL] [Abstract][Full Text] [Related]
15. Early preplasma cells define a tolerance checkpoint for autoreactive B cells.
Culton DA; O'Conner BP; Conway KL; Diz R; Rutan J; Vilen BJ; Clarke SH
J Immunol; 2006 Jan; 176(2):790-802. PubMed ID: 16393962
[TBL] [Abstract][Full Text] [Related]
16. Severe impairment of B cell function in lpr/lpr mice expressing transgenic Fas selectively on B cells.
Komano H; Ikegami Y; Yokoyama M; Suzuki R; Yonehara S; Yamasaki Y; Shinohara N
Int Immunol; 1999 Jul; 11(7):1035-42. PubMed ID: 10383935
[TBL] [Abstract][Full Text] [Related]
17. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
[TBL] [Abstract][Full Text] [Related]
19. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.
Santulli-Marotto S; Qian Y; Ferguson S; Clarke SH
J Immunol; 2001 Apr; 166(8):5292-9. PubMed ID: 11290816
[TBL] [Abstract][Full Text] [Related]
20. Hypogammaglobulinaemia occurs in Fas-deficient MRL-lpr mice following deletion of MHC class II molecules.
Anderson CC; Mukherjee R; Sinclair NR; Jevnikar AM
Clin Exp Immunol; 1997 Sep; 109(3):473-9. PubMed ID: 9328125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
